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Abstract
Background: Chronic migraine is a disabling, under-recognized, and undertreated disorder that increases health
burdens. The aim of this study was to evaluate phenotypic features and the relevance of accompanying symptoms
of migraine attacks in chronic migraine.
Method: This study was conducted as part of an ongoing Turkish Headache Database Study investigating the clinical
characteristics and outcomes of headache syndromes in the Turkish population. The electronic database was examined
retrospectively, and 835 patients with chronic migraine were included.
Results: Patient group consisted of 710 women and 125 men (85 and 15 %, respectively). Mean patient age was 36.8
± 13.5 years, median value of migraine onset was 60 months (18–120), median headache frequency was 25 days per
month (16–30), median of attack duration was 12 h (4–24), and median of intensity was eight (7–9). Increasing
headache days per month were inversely related with the presence of nausea, vomiting, phonophobia, and
photophobia. Longer duration of headache (months) and higher visual analog scale (VAS) for headache
intensity were associated with all accompanying symptoms. Phonophobia, nausea, photophobia, and vomiting
were the most frequent accompanying symptoms (experienced by 80.2, 77.6, 71.2, and 40.9 % of patients,
respectively). Osmophobia was also frequent in chronic migraine patients (53.4 %) and was closely associated
with other accompanying symptoms. Vertigo and dizziness were observed less frequently, and they were not
associated with accompanying symptoms.
Conclusion: Phenotype of chronic migraine may be associated with the course of chronification. Duration
of illness and attack intensity were closely related with the presence of accompanying symptoms, although
headache frequency was found to be inversely related to the presence of accompanying symptoms.
Osmophobia was also a frequent symptom and was closely related with other accompanied symptoms, unlike
vertigo and dizziness. Inclusion of osmophobia into the diagnostic criteria might improve accurate diagnosis
of chronic migraine.
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Background
Chronic migraine (CM) is defined by the presence of
headache attacks on 15 days or more per month for at
least three months of which 8 or more days meet criteria
for migraine [1]. A prevalence rate of 2 % for CM has
been estimated [2–4]. Although CM is much less com-
mon than episodic migraine (EM), it is substantially
more debilitating, with a greater negative effect on qual-
ity of life, and it is a challenging disorder for practi-
tioners [4, 5]. Despite the substantial personal and social
consequences of CM, its diagnostic criteria are still evolv-
ing [6]. The third edition of the International Classifica-
tion of Headache Disorders (ICHD-3 beta) [1], published
in 2013, has comprehensively described primary chronic
headache disorders, such as CM, chronic tension-type
headache, new daily persistent headache, and chronic
hemicrania continua [1]. In this new edition, medication
overuse headache is not an exclusion criterion; therefore,
CM now represents a broader patient group.
CM is a disabling, underdiagnosed, and undertreated
disorder [6]. CM patients constitute the most debilitated
subgroup of the migraine population, and may therefore
represent a clinically distinct group [7]. According to the
American Migraine Prevalence and Prevention study, pa-
tients with CM were twice as likely to develop depression,
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anxiety, and chronic pain than those with EM [8]. Cutane-
ous allodynia, anxiety, disability, and depression are fre-
quently considered as predictors of chronification [9, 10].
The explicit mechanisms of CM are not fully under-
stood. Atypical modulation of pain may play a role in its
pathogenesis [11]. Pain modulatory pathway alterations
have been identified in CM [12]. A suggested mechan-
ism for chronification of migraine is that repeated mi-
graine attacks could have cumulative structural effects
on the trigeminovascular pathway [13]. This theory is
supported by the evidence of iron deposition in the peri-
aqueductal gray matter of patients with a long history of
migraine [14]. In addition, CM is associated with a
greater degree of impairment in cortical processing of
sensory stimuli [15]. Therefore, proposed structural
changes in the excitability of the trigeminovascular path-
way and/or other brainstem pain modulating systems
could result in different phenotypes of the disease.
According to the ICHD-3 beta diagnostic criteria of mi-
graine, accompanying symptoms item (D) require either
(1) nausea and/or vomiting and/or (2) photophobia and
phonophobia. Although osmophobia is mentioned as an
accompanying symptom in the appendix-definitions sec-
tion, it has not been included in the diagnostic criteria.
Osmophobia refers to an increased sensitivity to odors
during migraine attacks, and it seems to be a distinguish-
ing feature of migraine [16]. Association between osmo-
phobia and allodynia has also been investigated recently,
and it is also proposed as a shared central sensitization
mechanism [17].
To the best of our knowledge, the association between
headache characteristics and accompanying symptoms of
CM has not been reported yet. The aims of this study are
(1) to determine the clinical characteristics of headache
attacks and to investigate the relevance of associated
symptoms such as nausea, vomiting, phonophobia, and
photophobia; (2) to investigate other associated symptoms
that could improve diagnostic certainty, including osmo-
phobia, dizziness, and vertigo; and (3) to analyze relation-
ships among associated symptoms.
Methods
This retrospective observational study was a part of
ongoing Turkish Headache Database (THD) Study. THD
investigating the clinical characteristics and outcomes of
primary and secondary headache syndromes in Turkish
population is supported by Turkish Neurological Society.
Out of tertiary headache centers in THD, patients diag-
nosed with CM based on ICHD-2 criteria between the
years 2008 and 2012 in Mersin University, Istanbul Uni-
versity and Kocaeli University were enrolled to this study.
The Human Ethical Committee of Mersin University
(MEU. 0.01.00.06/265, 20.10.2008) approved this non-
profit study. Subjects meeting the inclusion criteria were
enrolled into the study after giving written consent. Diag-
nosis of migraine was done by headache experts with face-
to-face examinations according to ICHD-2 criteria [18].
Subjects younger than 18 years of age and those older
than 80 years of age (n = 123 subjects), those who had
received a headache diagnosis other than CM (n = 2850
episodic migraine subjects), and patients with chronic
TTH, hemicrania continua, medication overuse headache
and patients who had TTH attacks more frequently than
migraine attacks (n = 385 subjects) were excluded. Data
on socio-demographic and clinical characteristics, includ-
ing age at onset, headache duration, headache frequency,
presence of aura, headache characteristics, localization,
intensity of pain, triggering factors, associated features, co-
morbidity, and medical and family history were gathered
from a web-based database. Accompanying symptoms of
CM were evaluated based on ICHD-2 criteria. Presence of
vertigo, dizziness and osmophobia were also analyzed
retrospectively taking into consideration of ICHD-3 beta
criteria. Vertigo and dizziness is stated when related with
migraine attacks. Vertigo definition based to clinical
features: internal/external vertigo, positional, occurring
during head motion. Similarly dizziness defined sensa-
tion of disequilibrium occurring during headache at-
tack, discrimination is particularly based to clinical
examination of experts.
When extracting data from the electronic database,
we excluded all missing data, including missing data
on accompanying symptoms. Therefore, we obtained a
reduced number of subjects in osmophobia assessments.
Although this could limit the power of the analysis, it also
increased the reliability of the data and prevented errors
that could be attributed to the retrospective design of the
study. The visual analog scale (VAS) was used for assess-
ment of pain intensity.
Statistical analysis
Data were entered and analyzed in the statistical analysis
program PASW v.18 (SPSS Inc. Released 2009, PASW
Statistics for Windows, Version 18.0. Chicago: SPSS
Inc.) statistical package. Distributions of data were ex-
amined with the Shapiro-Wilk test, and independent
samples t test and one-way ANOVA or non-parametric
alternatives (Mann–Whitney U and Kruskal-Wallis tests)
were used to compare groups according to the distribution
of dependent variables. Continuous variables were summa-
rized as mean ± standard deviation or median (25–75 %)
according to the distribution, and categorical variables were
summarized as frequency and percentile. Spearman non-
parametric correlations were used to analyze relationships
among headache properties. Pearson-Chi square or Fisher’s
exact test were used according to the expected count
rule for categorical data. Two-tailed p < 0.05 was ac-
cepted as significant.
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Results
The study group consisted of 835 CM patients, 710
female (85 %), mean age 36.8 ± 13.5 years. The median
value of migraine onset was 60 months (18–120), me-
dian headache duration was 12 h (4–24) and median
headache intensity was eight (7–9). Seventy-seven per-
cent of CM patients described throbbing headache
followed by pressing (13.7 %) and dull (5.5 %) headache.
The localization of headache was predominantly unilat-
eral (39.5 %), followed by bifrontal (10.7 %), generalized
(14.8 %), and sub-occipital (13.6 %). Phonophobia
(80.2 %) was the most common accompanying symptom,
followed by nausea (77.6 %) and photophobia (71.2 %).
Vomiting was present in 40.9 % of patients. Osmophobia
was observed in 53.4 % of patients, and dizziness and
vertigo was present in 17.5 % and 14.4 % of patients
respectively. Characteristics of study patients is summa-
rized at Table 1. The most common triggering factor
was emotional stress (79.2 %), followed by skipping
meals (57.0 %), menstruation (36.7 %), and seasonal fac-
tors (23.0 %). Most of the patients reported no intraday-
difference, but for 31.4 % of patients, headaches were
most intense in the evening. Headache frequency did
not change with age. Headache frequency was inversely
related with headache onset (r = -0.131, p < 0.001), attack
duration (r = -0.110, p = 0.002), and intensity of headache
(r = -0.118, p = 0.002). When correlation analysis adjusted
according to gender and age covariates; correlation of
headache onset disappeared, headache frequency was in-
versely related with attack duration (r = -0.083, p = 0.032),
and intensity of headache (r = -0.139, p < 0.001). Analysis
of gender effects revealed no difference between males
and females in terms of headache frequency (p = 0.589),
duration of illness (p = 0.054), or intensity (p = 0.559). At-
tack duration (hours) was significantly longer for females
(p < 0.001) (Table 2).
To reveal the phenotypic features of CM, we com-
pared headache frequency, duration of attack, intensity,
and duration of illness according to the presence of
accompanying symptoms. First, we compared headache
frequency (headache days per month) in terms of the
presence of accompanying symptoms. We observed that
the presence of nausea, vomiting, phonophobia, and
photophobia were significantly associated with fewer
headache days per month (Table 3). When we investi-
gated attack duration, we observed that vomiting, pho-
nophobia, and photophobia were associated with longer
duration of attack (Table 4). Greater headache intensity
(VAS) and longer duration of illness (in months) were sig-
nificantly associated with the existence of all accompany-
ing symptoms, including nausea, vomiting, phonophobia,
photophobia, dizziness, vertigo, and osmophobia (see
Tables 5 and 6 for intensity and duration, respectively).
We also analyzed the associations of accompanying
symptoms with each other (Table 7). The diagnostic ac-
companying symptoms described in ICHD-2 and also in
ICHD-3 beta are nausea, vomiting, phonophobia, and
photophobia, and these symptoms were found to be
closely related with each other (p = 0.001). The crosstab
analysis revealed that osmophobia and dizziness were sig-
nificantly correlated with the presence of other diagnostic
accompanying symptoms. By using x2 tests, we found that
osmophobia was associated with more frequent incidences
of nausea (p = 0.006), vomiting (p = 0.013), phonophobia
(p = 0.001), and photophobia (p = 0.001). Dizziness was
associated with more frequent incidences of nausea
(p = 0.008), vomiting (0.001), phonophobia (p = 0.001),
and photophobia (p = 0.001). The presence of vertigo was
Table 1 Headache characteristics of study group
Gender
Female 710 (85 %)
Male 125 (15 %)
Age Age 36,8 ± 13,5
Headache characteristics
Duration of illness (months) 60 (18–120)
Headache frequency (days/month) 25 (16–30)
Headache duration (hours) 12 (4–24)
Headache intensity (VAS) 8 (7–9)
Quality of headache
(n = 817)
Throbbing headache 631 (77.2 %)
Pressing 112 (13.7 %)
Dull 45 (5.5 %)
Others 29 (3.5 %)
Headache localization
(n = 811)
Unilateral 320 (39.5 %)
Bifrontal 87 (10.7 %)
Generalized 120 (14.8 %)
Sub-occipital 110 (13.6 %)
Others 198 (21.4 %)
Accompanying
symptoms
Phonophobia (n = 792) 635 (80.2 %)
Nausea (n = 789) 612 (77.6 %)
Photophobia (n = 787) 560 (71.2 %)
Vomiting (n = 738) 302 (40.9 %)
Osmophobia (n = 238) 127 (53.4 %)
Dizziness (n = 661) 116 (17.5 %)
Vertigo (n = 641) 92 (14.4 %)
VAS visual analog scale






Headache frequency (days/month) 20 [16–30] 25 [16–30] 0.589
Duration of illness (months) 48 [12–120] 60 [24–132] 0.054
Headache duration (hours) 7 [2–24] 12 [4–24] <0.001
Headache intensity (VAS) 8 [7–9] 8 [7–9] 0.559
VAS visual analog scale
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not associated with nausea (p = 0.445), vomiting (p = 0.142),
or photophobia (p = 0.063). A detailed analysis of the
accompanying symptoms is presented in Table 7.
Discussion
Our study revealed that the presence of diagnostic accom-
panying symptoms (nausea, vomiting, phonophobia, and
photophobia) lessened with higher numbers of headache
days per month. This finding is compatible with the litera-
ture. Migraine characteristics, especially accompanying
symptoms, are less prominent in the CM population [19].
This could be important for two reasons: first the absence
of accompanying symptoms could lead to underdiagnosis
of CM. Second, this observation could point to cumulative
effects of frequent headaches. CM is described as an
altered entity, and there is growing evidence of chronicity-
related structural effects in pain pathways [20]. Interest-
ingly, in our population, headache frequency did not
change with age or gender. Duration of illness and in-
tensity scores (VAS) were also similar for both genders.
However, headache duration was significantly longer in
females. Slater et al. reported longer headache duration









Nausea Present 612 20 [15–30] 0.008
Absent 177 30 [16–30]
Vomiting Present 302 20 [15–30] <0.001
Absent 436 30 [18–30]
Phonophobia Present 635 20 [15–30] 0.002
Absent 157 30 [20–30]
Photophobia Present 560 20 [15–30] <0.001
Absent 227 30 [20–30]
Dizziness Present 116 25 [16–30] 0.056
Absent 545 20 [16–30]
Vertigo Present 92 25 [16–30] 0.440
Absent 549 24 [16–30]
Osmophobia Present 127 20 [16–30] 0.371
Absent 111 20 [15–30]









Nausea Present 612 12 [4–24] 0.056
Absent 177 12 [3–24]
Vomiting Present 302 19 [6–24] <0.001
Absent 436 12 [3–24]
Phonophobia Present 635 12 [4–24] 0.010
Absent 157 11 [4–24]
Photophobia Present 560 12 [4–24] 0.003
Absent 227 10 [3–24]
Dizziness Present 116 12 [6–24] 0.148
Absent 545 12 [4–24]
Vertigo Present 92 12 [5–24] 0.826
Absent 549 12 [4–24]
Osmophobia Present 127 12 [7–24] 0.219
Absent 111 12 [4–24]









Nausea Present 612 8 [7–10] <0.001
Absent 177 7 [6–9]
Vomiting Present 302 8 [7–10] <0.001
Absent 436 7 [6–9]
Phonophobia Present 635 8 [7–10] <0.010
Absent 157 7 [6–8]
Photophobia Present 560 8 [7–10] <0.001
Absent 227 7 [6–8]
Dizziness Present 116 8 [7–10] 0.004
Absent 545 8 [7–9]
Vertigo Present 92 8 [7–10] 0.006
Absent 549 8 [7–9]
Osmophobia Present 127 8 [7–10] 0.032
Absent 111 8 [7–9]









Nausea Present 612 60 [24–156] <0.001
Absent 177 36 [10–114]
Vomiting Present 302 108 [36–180] <0.001
Absent 436 36 [12–120]
Phonophobia Present 635 60 [24–156] <0.001
Absent 157 36 [9–96]
Photophobia Present 560 72 [24–166] <0.001
Absent 227 36 [12–96]
Dizziness Present 116 114 [36–240] <0.001
Absent 545 48 [12–120]
Vertigo Present 92 82 [24–180] 0.015
Absent 549 48 [12–120]
Osmophobia Present 127 120 [48–240] <0.001
Absent 111 48 [12–120]
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in females in childhood migraine [21]. Adult popula-
tion studies also report longer headache duration in
females [22, 23], suggesting a female gender tendency
in CM.
Both duration of illness (months) and headache inten-
sity (VAS) scores were found to be significantly associ-
ated with the presence of all accompanying symptoms,
including nausea, vomiting, phonophobia, photophobia,
dizziness, vertigo, and osmophobia. Although our study
covered only CM patients, our results indicate that dur-
ation of illness and headache intensity are closely related
with accompanying symptoms. Kelman et al. reported
that headache intensity was correlated with nausea,
vomiting, photophobia, phonophobia, and dizziness, and
headache duration was correlated with osmophobia and
taste abnormalities [23]. In our results, accompanying
symptoms were present as hallmarks of duration of
illness and attack intensity in the CM population.
Attack duration was found to be related to the presence
of vomiting, phonophobia, and photophobia. However,
the presence of other accompanying symptoms—includ-
ing nausea, osmophobia, vertigo, and dizziness—did not
change with varying attack duration. Conversely, Kelman
and Tanis reported a correlation between attack duration
and osmophobia and taste abnormalities. However, their
study also covered EM patients [23]. This difference could
point to the effects of chronification on attack phenotype.
Finally, we analyzed the relationships of associated
symptoms with each other. The results revealed that
nausea, vomiting, phonophobia, and photophobia are
closely correlated with each other. Osmophobia (53.4 %)
was also a common accompanying symptom. In addition,
the presence of osmophobia was significantly associated
with other diagnostic accompanying symptoms. Because
ICHD-3 beta did not include other common symptoms
accompanying diagnostic criteria, there is insufficient data
investigating the predictive value of such symptoms. The
diagnostic utility of osmophobia was proposed previously
by some authors, especially for Asian migraineurs, in
whom photophobia is less common [16]. Similarly, Silva-
Neto et al. reported that osmophobia may be a specific
marker for migraine and suggested its inclusion within the
diagnostic criteria [24]. According to a recent study, the
prevalence of both allodynia and osmophobia were higher
in chronic than in episodic migraineurs [17]. Same study
also reported a relationship between duration of headache
and osmophobia.
This study has some limitations. First, the retrospective
study design limited our data to monitoring blood pres-
sure, body mass index, and educational-socioeconomic
Table 7 Associations of accompanying symptoms with each other
Nausea Vomiting Phonophobia Photophobia Dizziness Vertigo Osmophobia
Nausea + 51.2 86.1 77.4 19.7 14.9 57.8
- 7.9 58.0 47.4 10.6 12.4 35.4
p 0.001 0.001 0.001 0.008 0.445 0.006
Vomiting + 95.3 88.2 83.1 25.0 16.5 59.8
- 62.6 71.9 59.4 12.6 12.4 43.1
p 0.001 0.001 0.001 0.001 0.142 0.013
Phonophobia + 83.5 45.5 82.1 20.4 16.8 59.6
- 52.9 22.3 27.4 6.6 6.6 19.5
p 0.001 0.001 0.001 0.001 0.002 0.001
Photophobia + 84.7 48.8 92.3 21.2 16.0 59.7
- 59.3 22.1 49.6 9.3 10.5 28.0
p 0.001 0.001 0.001 0.001 0.063 0.001
Dizziness + 85.2 55.3 91.2 85.2 50.0 71.3
- 73.5 34.7 73.9 64.0 6.2 32.0
p 0.008 0.001 0.001 0.001 0.001 0.001
Vertigo + 78.0 44.9 89.1 75.8 59.3 65.7
- 74.3 36.8 74.3 65.9 8.8 39.9
p 0.445 0.142 0.002 0.063 0.001 0.001
Osmophobia + 86.4 53.5 93.5 88.8 60.8 43.6
- 71.8 36.9 70.3 67.6 22.7 21.1
p 0.006 0.013 0.001 0.001 0.001 0.001
In this table, + lines indicate subjects who had related symptoms, and – lines indicate subjects who did not have related symptoms
Yalın et al. The Journal of Headache and Pain  (2016) 17:26 Page 5 of 6
status. Second, this study did not include EM patients, so
we could not compare our findings with those of EM
sufferers. Due to the retrospective design of this study
some missing values of the parameters was one of our
limitations. But even so power analysis of the data is
mostly estimated 80–99 % for variables. However, this
study gives us clues about the determinants of phenotype
in CM populations.
Conclusion
In conclusion, our study supports and expands the litera-
ture and could be summarized as follows: (1) CM is de-
fined as 15–30 headache days per month, and in our study
population, higher numbers of headache days were found
to be correlated with less prominent nausea, vomiting,
photophobia, and phonophobia; (2) long duration of head-
ache (months) and higher attack intensity (VAS) were
found to be correlated with more frequent incidences of all
accompanying symptoms investigated; (3) longer attack
duration (hours) was found to be correlated with the
presence of vomiting and phono-photophobia; (4) dur-
ation of headache and attack intensity are the most
relevant determinants of CM attack phenotype; (5)
osmophobia is also common in CM and is associated
with diagnostic accompanying symptoms; and (6) dizzi-
ness and vertigo were less frequent in the CM popula-
tion and do not have a prominent relationship with
other diagnostic accompanying symptoms.
Future studies focusing on clinical presentation and
accompanying symptoms could provide additional data
to shed light on the phenotypes, classifications, and
pathophysiological pathways of chronicity.
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